– Reuters
Baird Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $18
Baird analyst Joel Beatty maintains IDEAYA Biosciences (NASDAQ: IDYA) with a Outperform and lowers the price target from $26 to $18.Baird analyst Joel Beatty maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target fro